《Every Stock I'm Buying in September 2026 (Huge Opportunities)》
PFE 在估值与股息方面是最佳的生物科技标的，被视为稳健的长期持有品种。
辉瑞，在我看来，就整体估值和股息而言，辉瑞目前是最好的生物科技公司。所以，是的，我们的仓位有点重，但我认为这没关系。它只占投资组合的4%左右。
Um Fizer, you know, in my opinion, Fizer is like the best like biotech in terms of an overall package valuation dividend wise right now. So, yeah, we're we are a little heavy on it, but I think that's okay. It's only around 4% of the portfolio.
所以，再说辉瑞，就估值和股息而言，它整体上是最好的生物科技公司。我认为它是一只稳健的生物科技、制药标的，随便你怎么称呼它。
So, Fizer, again, it's like the overall best biotech in terms of valuation and dividend. I think it's a solid biotech uh pharmaceutical play, whatever you want to call it,